Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Elanco history
Elanco company history timeline
Shortly after, in 1954, the company formally organized its plant and animal science activities into the Agricultural and Industrial Sales Division, led by George Varnes.
The Elanco brand, short for Eli Lilly and Company, came to be in 1960, following the reorganization of Eli Lilly and Company's Agricultural and Industrial Sales Division.
In 2007 the business acquired Ivy Animal Health and launched its companion animal business.
In 2008 Elanco partnered with Heifer International in order to address food security in developing nations.
In 2009 the business launched its data analytics business, Elanco Knowledge Solutions.
In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site.
In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health and committed to ending hunger for 100,000 families through the Heifer International partnership.
In 2012 the business acquired ChemGen Corp., improving their offering in enzyme-based nutrient absorption tools for food-livestock.
In 2016 Elanco expanded its US-based business, acquiring a suite of vaccines from Boehringer Ingelheim Vetmedica for $885 million.
On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area.
In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences, enhancing its existing biologics and monoclonal antibody pipeline.
The business plans to break ground on the new headquarters in the first half of 2021.
Elanco's Healthy Purpose, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2022 Elanco or its affiliates.EM-GLB-CA-20-0045
Rate Elanco's efforts to communicate its history to employees.
Elanco jobs
Do you work at Elanco?
Does Elanco communicate its history to new hires?
Elanco competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Zoetis | 1952 | $9.3B | 11,300 | 252 |
| Merck | 1891 | $64.2B | 74,000 | 1,306 |
| Warner Chilcott | 1968 | $105.1M | 3,000 | - |
| Sun Pharmaceutical Industries Inc. | 1984 | $4.2B | 32,000 | 124 |
| Roche Holding AG | 1987 | $61.0B | 94,442 | 239 |
| Watson Pharma Pvt Ltd | 1984 | $5.9B | 21,600 | - |
| West-Ward Pharmaceuticals | 1946 | $150.0M | 249 | 55 |
| Mallinckrodt | 1867 | $1.0B | 3,400 | 69 |
| Mylan | 1961 | $11.5B | 35,000 | 3 |
| Paddock Laboratories | 1977 | $100.5M | 51 | - |
Elanco history FAQs
Zippia gives an in-depth look into the details of Elanco, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Elanco. The employee data is based on information from people who have self-reported their past or current employments at Elanco. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Elanco. The data presented on this page does not represent the view of Elanco and its employees or that of Zippia.
Elanco may also be known as or be related to Elanco, Elanco Animal Health and Elanco Animal Health Incorporated.